V-COVID
Understanding community transmission of COVID-19 in Vietnam
See news from our COVID-19 projects:
COVID- 19 research updates, February 2021
Cập nhật kết quả nghiên cứu về COVID- 19, Tháng 2 Năm 2021
View publications for this project
AUSTRALIAN PRINCIPAL INVESTIGATOR: Professor Greg Fox, The University of Sydney and the Woolcock Institute of Medical Research
V-COVID 1: Serological evaluation of the community spread of SARS-CoV-2
STUDY SITES: Hanoi, Da Nang, Quang Nam
TIMELINE: 2020-2021
PROJECT IMPLEMENTER: National Hospital of Tropical Diseases
FUNDED BY: Department of Foreign Affairs and Trade
CORE STAKEHOLDERS: National Hospital of Tropical Diseases, Provincial Department of Health and Provincial CDC, Provincial Lung Hospitals.
PRIMARY OBJECTIVES: To ascertain unbiased estimates of the key parameters informing predictive models for COVID-19 and, hence, (1) to enable evidence-based policy decisions on testing, isolation, quarantine and social distancing interventions, (2) to predict the subsequent course of the epidemic, and (3) to understand the extent of transmission within high-risk populations.
V-COVID 2: Strategies for health system preparedness to scale up vaccines for COVID-19 in Vietnam
STUDY SITES: Nationwide
TIMELINE: 2020-2021
PROJECT IMPLEMENTER: Hanoi University of Public Health
FUNDED BY: Department of Foreign Affairs and Trade
CORE STAKEHOLDERS: Hanoi University of Public Health, National Institute of Hygiene and Epidemiology
PRIMARY OBJECTIVE: To develop a framework of analysis and a model of scenarios that acknowledges some of the key challenges and decision points related to vaccine development and rollout.
V-COVID 3: Characterising the attitudes towards COVID-19 in the community
STUDY SITES: Hanoi, Da Nang, Quang Nam, Ho Chi Minh City
TIMELINE: 2020-2021
PROJECT IMPLEMENTER: National Hospital of Tropical Diseases
FUNDED BY: Department of Foreign Affairs and Trade
CORE STAKEHOLDERS: National Hospital of Tropical Diseases
PRIMARY OBJECTIVES:
To explore the current and future role of the pharmacy sector at a community level in responding to COVID-19 in Vietnam.
To explore community experiences and engagement with the public health response and communication around COVID-19 (including experiences of stigma).
V-COVID 4: The impact of the COVID-19 pandemic on the care of tuberculosis patients in Vietnam
STUDY SITES: Nationwide
TIMELINE: 2020-2022
PROJECT IMPLEMENTER: National Lung Hospital
FUNDED BY: Department of Foreign Affairs and Trade
CORE STAKEHOLDERS: National Lung Hospital
PRIMARY OBJECTIVE: To quantify the effect the COVID-19 outbreak may have had in the provision and outcomes of TB care in Vietnam, and to provide recommendations on strategies to mitigate and support patients who are being treated for TB during this pandemic and in the future.
V-COVID 5: Understand the effect of COVID-19 upon drug-resistant tuberculosis
STUDY SITES: Hanoi, Nam Dinh, Thanh Hoa, Khanh Hoa, Da Nang, Quang Nam, Ho Chi Minh City, Tien Giang, An Giang, Can Tho
TIMELINE: 2020-2022
PROJECT IMPLEMENTER: National Lung Hospital
FUNDED BY: Department of Foreign Affairs and Trade
CORE STAKEHOLDERS: National Lung Hospital
PRIMARY OBJECTIVE: To estimate the effect of COVID-19 upon reactivation of drug-resistant latent tuberculosis infection.
V-COVID 6: Radiological and clinical characteristics of patients hospitalised with laboratory-confirmed COVID-19 in Vietnam
STUDY SITES: Hanoi
TIMELINE: 2020
PROJECT IMPLEMENTER: National Hospital of Tropical Diseases
FUNDED BY: Department of Foreign Affairs and Trade
CORE STAKEHOLDERS: National Hospital of Tropical Diseases
PRIMARY OBJECTIVE: To characterise chest x-ray abnormalities among hospitalised patients with confirmed SARS-CoV2 infection and compare their clinical and laboratory characteristics.
V-COVID 7: Symptom screening for COVID-19 suspect cases in community pharmacies
STUDY SITES: Hanoi
TIMELINE: 2020-2021
PROJECT IMPLEMENTER: Department of Health
FUNDED BY: Department of Foreign Affairs and Trade
CORE STAKEHOLDERS: Department of Health
PRIMARY OBJECTIVE: To develop a guideline and communication materials to screen for symptoms of COVID-19 infection in customers visiting pharmacies, and to provide a safe and ongoing service to both pharmacy staff and customers.
Publications
COVID-19 collaborative modelling for policy response in the Philippines, Malaysia and Vietnam, The Lancet Regional Health - Western Pacific
Prevalence and genetic basis of first line drug resistance of M. tuberculosis in Ca Mau, Vietnam, ERJ Open Research. Accepted for publication
Epidemiological approach to ending tuberculosis in high-burden countries, The Lancet
Sero-prevalence of SARS-CoV-2 in high-risk populations in Vietnam. Emerg Infect Dise 2021 (Accepted 16/12/2021)
Modelling the impact of COVID-19 upon intensive care services in New South Wales, The Medical Journal of Australia
Tuberculosis and COVID-19 co-infection: description of the global cohort, European Respiratory Journal
The prevalence of SARS-CoV-2 antibodies in quarantine workers and high-risk communities in Vietnam, International Journal of Environmental Research and Public Health Regions
Sero-prevalence of SARS-CoV-2 antibodies in high-risk populations in Vietnam, International Journal of Environmental Research and Public Health
Emergency department patients from quarantine hotels in Sydney Australia during the COVID19 outbreak – an analysis of presentation types and outcomes, The Medical Journal of Australia (Accepted 16/3/21)
Experience in responding to COVID-19 outbreaks from Vietnam, The Lancet Western Pacific
Modelling the impact of COVID-19 upon intensive care services in New South Wales, The Medical Journal of Australia
Estimation of the incubation period of SARS-CoV-2 in Vietnam, PLOS ONE
How can airborne transmission of COVID-19 indoors be minimised?, Environment International
Modelling the impact of control measures against the COVID-19 pandemic in Viet Nam, medRxiv
Outbreak investigation for COVID-19 in northern Vietnam, The Lancet Infectious Diseases
Adapting a TB contact investigation strategy for COVID-19, The International Journal of Tuberculosis and Lung Disease